FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103297906> ?p ?o ?g. }

• W2103297906 endingPage "262" @default.
• W2103297906 startingPage "253" @default.
• W2103297906 abstract "1. The ability of the endogenous fatty acid amide, cis-oleamide (ODA), to bind to and activate cannabinoid CB(1) and CB(2) receptors was investigated. 2. ODA competitively inhibited binding of the nonselective cannabinoid agonist [(3)H]CP55,940 and the selective CB(1) antagonist [(3)H]SR141716A to rat whole-brain membranes with K(i) values of 1.14 microm (0.52-2.53 microm, Hill slope=0.80, n=6) and 2.63 microm (0.62-11.20 microm, Hill slope=0.92, n=4), respectively. AEA inhibited [(3)H]CP55,940 binding in rat whole-brain membranes with a K(i) of 428 nm (346-510 nm, Hill slope=-1.33, n=3). 3. ODA competitively inhibited [(3)H]CP55,940 binding in human CB(1) (hCB(1)) cell membranes with a K(i) value of 8.13 microm (4.97-13.32 microm, n=2). In human CB(2) transfected (hCB(2)) HEK-293T cell membranes, 100 microm ODA produced only a partial (42.5+/-7%) inhibition of [(3)H]CP55,940 binding. 4. ODA stimulated [(35)S]GTPgammaS binding in a concentration-dependent manner (EC(50)=1.64 microm (0.29-9.32 microm), R(2)=0.99, n=4-9), with maximal stimulation of 188+/-9% of basal at 100 microm. AEA stimulated [(35)S]GTPgammaS binding with an EC(50) of 10.43 microm (4.45-24.42 microm, R(2)=1.00, n=3, 195+/-4% of basal at 300 microm). Trans-oleamide (trans-ODA) failed to significantly stimulate [(35)S]GTPgammaS binding at concentrations up to 100 microm. 5. ODA (10 microm)-stimulated [(35)S]GTPgammaS binding was reversed by the selective CB(1) antagonist SR141716A (IC(50)=2.11 nm (0.32-13.77 nm), R(2)=1.00, n=6). 6. The anatomical distribution of ODA-stimulated [(35)S]GTPgammaS binding in rat brain sections was indistinguishable from that of HU210. Increases of similar magnitude were observed due to both agonists in the striatum, cortex, hippocampus and cerebellum. 7. ODA (10 microm) significantly inhibited forskolin-stimulated cyclic AMP (cAMP) accumulation in mouse neuroblastoma N1E 115 cells (P=0.02, n=11). ODA-mediated inhibition was completely reversed by 1 microm SR141716A (P<0.001, n=11) and was also reversed by pretreatment with 300 ng ml(-1) pertussis toxin (P<0.001, n=6). 8. These data demonstrate that ODA is a full cannabinoid CB(1) receptor agonist. Therefore, in addition to allosteric modulation of other receptors and possible entourage effects due to fatty acid amide hydrolase inhibition, the effects of ODA may be mediated directly via the CB(1) receptor." @default.
• W2103297906 created "2016-06-24" @default.
• W2103297906 creator A5030447237 @default.
• W2103297906 creator A5050639889 @default.
• W2103297906 creator A5073049066 @default.
• W2103297906 creator A5079007370 @default.
• W2103297906 creator A5080308855 @default.
• W2103297906 date "2004-01-01" @default.
• W2103297906 modified "2023-10-01" @default.
• W2103297906 title "Oleamide is a selective endogenous agonist of rat and human CB₁ cannabinoid receptors" @default.
• W2103297906 cites W1506258765 @default.
• W2103297906 cites W1651476949 @default.
• W2103297906 cites W1830687359 @default.
• W2103297906 cites W1844090762 @default.
• W2103297906 cites W190123861 @default.
• W2103297906 cites W1931308193 @default.
• W2103297906 cites W1935108555 @default.
• W2103297906 cites W1936589897 @default.
• W2103297906 cites W1943648506 @default.
• W2103297906 cites W1950723000 @default.
• W2103297906 cites W1966231083 @default.
• W2103297906 cites W1975161769 @default.
• W2103297906 cites W1976899484 @default.
• W2103297906 cites W1977107035 @default.
• W2103297906 cites W1981936285 @default.
• W2103297906 cites W1989073099 @default.
• W2103297906 cites W1991461690 @default.
• W2103297906 cites W1992388910 @default.
• W2103297906 cites W1992753989 @default.
• W2103297906 cites W2000082939 @default.
• W2103297906 cites W2010227307 @default.
• W2103297906 cites W2015614945 @default.
• W2103297906 cites W2025509480 @default.
• W2103297906 cites W2031823540 @default.
• W2103297906 cites W2042544913 @default.
• W2103297906 cites W2046614626 @default.
• W2103297906 cites W2049770492 @default.
• W2103297906 cites W2053209637 @default.
• W2103297906 cites W2059784467 @default.
• W2103297906 cites W2059997087 @default.
• W2103297906 cites W2064685985 @default.
• W2103297906 cites W2064876535 @default.
• W2103297906 cites W2065793570 @default.
• W2103297906 cites W2071631452 @default.
• W2103297906 cites W2073999787 @default.
• W2103297906 cites W2075362359 @default.
• W2103297906 cites W2094600724 @default.
• W2103297906 cites W2098730433 @default.
• W2103297906 cites W2099292182 @default.
• W2103297906 cites W2100338555 @default.
• W2103297906 cites W2104449978 @default.
• W2103297906 cites W2115202208 @default.
• W2103297906 cites W2115754584 @default.
• W2103297906 cites W2128635872 @default.
• W2103297906 cites W2129714107 @default.
• W2103297906 cites W2131054307 @default.
• W2103297906 cites W2139261360 @default.
• W2103297906 cites W2156019215 @default.
• W2103297906 cites W2418870034 @default.
• W2103297906 cites W4293247451 @default.
• W2103297906 doi "https://doi.org/10.1038/sj.bjp.0705607" @default.
• W2103297906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1574194" @default.
• W2103297906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14707029" @default.
• W2103297906 hasPublicationYear "2004" @default.
• W2103297906 type Work @default.
• W2103297906 sameAs 2103297906 @default.
• W2103297906 citedByCount "157" @default.
• W2103297906 countsByYear W21032979062012 @default.
• W2103297906 countsByYear W21032979062013 @default.
• W2103297906 countsByYear W21032979062014 @default.
• W2103297906 countsByYear W21032979062015 @default.
• W2103297906 countsByYear W21032979062016 @default.
• W2103297906 countsByYear W21032979062017 @default.
• W2103297906 countsByYear W21032979062018 @default.
• W2103297906 countsByYear W21032979062019 @default.
• W2103297906 countsByYear W21032979062020 @default.
• W2103297906 countsByYear W21032979062021 @default.
• W2103297906 countsByYear W21032979062022 @default.
• W2103297906 countsByYear W21032979062023 @default.
• W2103297906 crossrefType "journal-article" @default.
• W2103297906 hasAuthorship W2103297906A5030447237 @default.
• W2103297906 hasAuthorship W2103297906A5050639889 @default.
• W2103297906 hasAuthorship W2103297906A5073049066 @default.
• W2103297906 hasAuthorship W2103297906A5079007370 @default.
• W2103297906 hasAuthorship W2103297906A5080308855 @default.
• W2103297906 hasBestOaLocation W21032979062 @default.
• W2103297906 hasConcept C148001335 @default.
• W2103297906 hasConcept C170493617 @default.
• W2103297906 hasConcept C185592680 @default.
• W2103297906 hasConcept C2778684643 @default.
• W2103297906 hasConcept C2778938600 @default.
• W2103297906 hasConcept C2780433416 @default.
• W2103297906 hasConcept C2780871563 @default.
• W2103297906 hasConcept C55493867 @default.
• W2103297906 hasConcept C71240020 @default.
• W2103297906 hasConceptScore W2103297906C148001335 @default.
• W2103297906 hasConceptScore W2103297906C170493617 @default.
• W2103297906 hasConceptScore W2103297906C185592680 @default.

• next